C3 and glioblastoma: DeCordova et al. showed that cultured primary tumor cells isolated from glioblastoma patients secrete functionally active FHR5, which regulates the complement by acting as a cofactor for factor I-mediated cleavage of C3b, and degrading (decaying) C3 convertase.